O. Papaioannou

发表

Infliximab-induced interstitial lung disease

T. Karampitsakos, A. Tzouvelekis, F. Sampsonas, 2021, BMJ Case Reports.

CTPA imaging findings, beyond pulmonary embolism, in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection and their relation to clinical outcome - a single center experience.

P. Zampakis, T. Karampitsakos, M. Marangos, 2022, European review for medical and pharmacological sciences.

Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study

K. Kostikas, S. Loukides, S. Papiris, 2021, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidism

K. Kotsa, R. Sklavenitis-Pistofidis, O. Papaioannou, 2015, Hormones.

Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis

K. Kostikas, Z. Daniil, K. Gourgoulianis, 2021, Respiratory Research.

Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic.

N. Koulouris, S. Loukides, A. Tzouvelekis, 2021, Advances in respiratory medicine.

Low penetrance of antibiotics in the epithelial lining fluid. Experience from the use of inhaled antibiotics in patients with non CF-bronchiectasis.

D. Bouros, T. Karampitsakos, E. Stavropoulou, 2019, Pulmonary pharmacology & therapeutics.

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial

A. Kalogeropoulos, A. Tzouvelekis, K. Akinosoglou, 2022, Clinical Microbiology and Infection.

Diagnostic Accuracy of Multiple D-Dimer Cutoff Thresholds and Other Clinically Applicable Biomarkers for the Detection and Radiographic Evaluation of Pulmonary Embolism

T. Karampitsakos, A. Tzouvelekis, L. Thanos, 2022, Advances in respiratory medicine.

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study

S. Loukides, Demosthenes Bouros, K. Akinosoglou, 2020, Frontiers in Medicine.

Bronchoscopy during the COVID-19 pandemic: effect on current practices and strategies to reduce procedure-associated transmission

T. Karampitsakos, A. Tzouvelekis, G. Kyriakou, 2021, Expert review of respiratory medicine.

Metabolic Disorders in Chronic Lung Diseases

N. Xylourgidis, Demosthenes Bouros, T. Karampitsakos, 2018, Front. Med..

Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective study

A. Tzouvelekis, K. Akinosoglou, D. Velissaris, 2021, Respiratory Research.

High-Flow vs. Low-Flow Nasal Cannula in Reducing Hypoxemic Events During Bronchoscopic Procedures: A Systematic Review and Meta-Analysis

G. Stratakos, D. Velissaris, T. Karampitsakos, 2022, Frontiers in Medicine.

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model

C. Kalogeropoulou, D. Bouros, A. Kazantzi, 2021, Respiration.

Thoracic endosonography (EBUS/EUS‐b) in the diagnosis of different intrathoracic diseases: A 4‐year experience at a single‐centre in Greece

E. Zervas, T. Karampitsakos, A. Tzouvelekis, 2020, International journal of clinical practice.

Post-COVID-19 interstitial lung disease: Insights from a machine learning radiographic model

A. Tzouvelekis, K. Antoniou, N. Tzanakis, 2023, Frontiers in Medicine.

Clinical features and outcomes of patients with myositis associated-interstitial lung disease

Demosthenes Bouros, A. Tzouvelekis, V. Tzilas, 2021, Frontiers in Medicine.

What is new in the treatment of interstitial lung diseases

T. Karampitsakos, A. Tzouvelekis, Fotios, 2023 .

Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis

Z. Daniil, K. Gourgoulianis, Demosthenes Bouros, 2022, ERJ Open Research.

Tocilizumab in Hospitalized Patients with Severe COVID-19: An Open Label, Prospective Study

A. Tzouvelekis, K. Akinosoglou, D. Velissaris, 2021 .

The role of increased red cell distribution width as a negative prognostic marker in patients with COPD.

D. Bouros, T. Karampitsakos, A. Tzouvelekis, 2019, Pulmonary pharmacology & therapeutics.

Interstitial Lung Diseases and the Impact of Gender.

A. Tzouvelekis, T. Karampitsakos, F. Sampsonas, 2021, Clinics in Chest Medicine.

Epidemiological characteristics, clinical features and outcomes of patients with COVID-19 admitted to seven reference centers across Greece: An observational study during the fourth and fifth waves of the COVID-19 pandemic

K. Kostikas, S. Loukides, Emmanouil Alevrakis, 2023, Pneumon.

Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis.

K. Akinosoglou, T. Karampitsakos, V. Georgiopoulou, 2022, European Review for Medical and Pharmacological Sciences.

Fanconi syndrome-associated interstitial lung disease

T. Karampitsakos, A. Tzouvelekis, F. Sampsonas, 2022, BMJ Case Reports.

Clinical features and outcomes of patients with myositis associated-interstitial lung disease

Demosthenes Bouros, A. Tzouvelekis, V. Tzilas, 2023, Frontiers in Medicine.

Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis

V. Aidinis, A. Tzouvelekis, J. Herazo-Maya, 2023, Respiratory Research.